Published on 27/12/2025
How to Schedule and Conduct Virtual Patient Visits in Decentralized Trials
Virtual patient visits are at the heart of Decentralized Clinical Trials (DCTs), enabling remote data collection, patient engagement, and reduced site dependency. These visits are conducted through secure telemedicine platforms and follow regulatory-approved protocols to ensure quality and compliance. This tutorial provides a step-by-step guide for pharma professionals and clinical trial teams on scheduling and conducting virtual visits effectively and ethically.
Importance of Virtual Patient Visits in DCTs:
Decentralized models shift trial operations from brick-and-mortar sites to patients’ homes. Virtual visits help:
- Reach patients in geographically diverse locations
- Increase trial accessibility for elderly or mobility-impaired individuals
- Improve retention by reducing participant burden
- Maintain engagement over long study durations
They are especially vital for chronic disease trials and stability studies in pharmaceuticals involving extended follow-up periods.
Telehealth Platform Features for Virtual Visits:
The selected platform must comply with regulatory standards and offer the following:
- End-to-end encryption for patient privacy
- Video/audio capability with screen sharing
- Automated scheduling and appointment reminders
- Integrated eConsent and data capture tools
- Session logging and metadata for auditing
Validated platforms such as Medable, Science 37, and Florence meet these criteria and support scalable DCT operations.
Scheduling Virtual Visits: Workflow & Tools
- Define Visit
Preparation Before a Virtual Visit:
- Ensure participant has access to a smartphone/laptop with camera and stable internet
- Provide user-friendly login links or app access
- Train site staff and patients on platform usage
- Confirm eConsent completion and baseline documentation
- Prepare visit checklist based on protocol requirements
Conducting the Virtual Visit: Step-by-Step
- Verify Patient Identity: Ask for ID confirmation or unique login credentials
- Start Video Consultation: Engage using the approved platform
- Discuss Visit Objectives: Review treatment progress, side effects, and other protocol items
- Remote Data Capture: Use eCRFs or integrated tools for real-time entry
- Conclude and Confirm Next Visit: Log session details, provide summary, and book follow-up
Session duration, content, and outcome should be documented in the source file or electronic Trial Master File (eTMF), as per GMP documentation practices.
Compliance and Regulatory Expectations:
- USFDA requires source data integrity and traceability
- EMA supports remote visits under documented SOPs
- CDSCO mandates Ethics Committee approval for telemedicine use
Ensure that all virtual interactions are audit-ready with recorded metadata, such as time stamps, attendee log, and digital signatures.
Training Site Teams for Virtual Visit Execution:
Comprehensive training improves consistency and compliance:
- Role-playing patient interactions
- Simulation of adverse event reporting via teleconsultation
- eCRF data entry and remote query resolution
- Documentation of protocol deviations
Training should be documented as part of your SOP training pharma program and referenced in the Monitoring Plan.
Patient-Centric Considerations:
- Offer technical support hotline for patients
- Ensure cultural and language compatibility
- Maintain a warm and empathetic communication style
- Send follow-up summaries to enhance engagement
Handling Protocol-Specific Assessments Virtually:
Not all assessments can be done remotely, but many can be adapted, including:
- Patient-reported outcomes (ePROs)
- Symptom checklists and diaries
- Medication adherence confirmation
- Remote safety interviews and adverse event evaluations
Examples of Virtual Visit Protocol Elements:
Here’s how virtual visits may be mapped in a protocol:
| Visit No. | Timing | Mode | Assessment |
|---|---|---|---|
| Visit 1 | Screening | Virtual | eConsent, medical history |
| Visit 2 | Day 7 | Virtual | Symptom check, medication review |
| Visit 3 | Day 28 | Virtual | Adverse events, QoL survey |
Best Practices for Virtual Patient Visits:
- Use validated platforms and test tech before each session
- Ensure confidentiality and conduct sessions in private spaces
- Keep conversation focused on protocol-mandated topics
- Document deviations and reschedule promptly when needed
- Train all new staff before participation
Conclusion:
Virtual patient visits are redefining how clinical trials are executed. With the right telehealth infrastructure, SOPs, and regulatory compliance, sponsors and sites can deliver a seamless patient experience while maintaining data integrity and oversight. As decentralized models continue to expand, virtual visits will become a standard component of clinical trial design and conduct.